synthetic genomics
The INSIDER algorithm, which grew out of SARS-CoV-2 variant research, looks for shifts in k-mer signatures to streamline the search for novel genomic patterns.
Codex DNA Q2 Revenues Rise 76 Percent
The revenue increase was related to new products and a rise in royalties and collaboration research program revenue, according to the firm.
Codex DNA Closes $122.7M IPO
The San Diego-based synthetic nucleic acids company, formerly known as SGI-DNA, sold approximately 7.7 million shares at an offering price of $16 per share.
Twist Bioscience Q2 Revenues Grow 62 Percent
The synthetic DNA manufacturer missed the consensus Wall Street estimate for loss per share but beat analysts' estimate on the top line.
Molecular Assemblies Extends Series A Financing Round by $11.8M
The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund.
Feb 5, 2021
Dec 2, 2020
Twist Bioscience Proposes $250M Public Offering
Nov 23, 2020
Aug 6, 2020
Twist Bioscience Q3 Revenues Grow 56 Percent
Jun 4, 2020
Twist Bioscience Prices $100M Stock Offering
May 21, 2020
May 7, 2020
Twist Bioscience Q2 Revenues Increase 42 Percent
Jan 7, 2020
Dec 12, 2019